the most useful non genomic biomarkers for monitoring patients after initial treatment
Published 6 years ago • 119 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:28
ask the expert: which non genomic biomarkers are the most useful for stratifying patients?
-
1:18
which non-genomic biomarkers are the most useful for stratifying patients
-
10:59
non genomic biomarkers for early diagnosis and prognosis prevention of prostate cancer
-
10:11
mri-invisible prostate cancer and use of biomarkers to identify potential candidates
-
11:03
biomarkers for prostate cancer: whom to treat
-
10:28
diagnostic and prognostic biomarkers for prostate cancer
-
36:53
matthew cooperberg, md, mph on biomarkers in prostate cancer active surveillance
-
4:34
the fear of cancer & choosing active surveillance | ask a prostate expert, mark scholz, md
-
12:54
living with williams syndrome (a condition that makes you friendly)
-
12:46
what role do markers play in establishing active surveillance or definitive care?
-
12:48
micro ultrasound and mri of the prostate
-
15:10
imaging and biomarkers in patient selection for focal ablation
-
18:25
game changers in prostate cancer diagnostics: imaging probably wins the most
-
30:04
industry perspective: cxbladder monitor urine genomics test for surveillance of patients with nmibc
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
19:46
biomarkers: a way forward with prostate cancer early detection
-
10:04
there is a role for biomarkers/genomics in the risk stratification of prostate cancer
-
12:13
biomarkers’ integration with clinical parameters, imaging, and prognostic instruments
-
2:04
biomarkers for bladder cancer
-
24:38
can genomics improve upon best clinical risk stratification?
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
15:34
therapy for high risk nmibc